Literature DB >> 8611439

Pernicious anaemia and cancer risk in Denmark.

L Mellemkjaer1, G Gridley, H Møller, A W Hsing, M S Linet, L A Brinton, J H Olsen.   

Abstract

A cohort of 5072 patients with pernicious anaemia was identified in the Danish Hospital Discharge Register from 1977 to 1989 and, through linkage to the Danish Cancer Registry, the occurrence of cancer in the cohort was determined up to 1991. Observed numbers of cancer cases during 1-15 years of follow-up were compared with expected numbers based on national incidence rates. Besides the well-established increased risk for stomach cancer, the analysis also revealed a 2-fold increase in the relative risk for cancer of the buccal cavity and pharynx among pernicious anaemia patients in accordance with previous studies; previously reported elevated risks for other digestive tract cancers were not confirmed. There was a non-significantly increased risk for lymphatic and haematological malignancy but the risk tended to disappear after 5 years of follow-up, indicating a possible selection bias. Decreased risks for cervical cancer and non-melanoma skin cancer were also seen.

Entities:  

Mesh:

Year:  1996        PMID: 8611439      PMCID: PMC2075829          DOI: 10.1038/bjc.1996.195

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  Increased incidence of pancreatic neoplasia in pernicious anemia.

Authors:  K Borch; E Kullman; S Hallhagen; T Ledin; I Ihse
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

2.  Possible association between pernicious anaemia and leukaemia: a prospective study of 1,625 patients with a note on the very high incidence of stomach cancer.

Authors:  E K Blackburn; S T Callender; J V Dacie; R Doll; R H Girdwood; D L Mollin; R Saracci; J L Stafford; R B Thompson; S Varadi; G Wetherley-Mein
Journal:  Int J Cancer       Date:  1968-01-15       Impact factor: 7.396

3.  Pernicious anemia and subsequent cancer. A population-based cohort study.

Authors:  A W Hsing; L E Hansson; J K McLaughlin; O Nyren; W J Blot; A Ekbom; J F Fraumeni
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

4.  Pernicious anaemia as a risk factor in gastric cancer.

Authors:  L Elsborg; J Mosbech
Journal:  Acta Med Scand       Date:  1979

5.  Cancer risk following pernicious anaemia.

Authors:  L A Brinton; G Gridley; Z Hrubec; R Hoover; J F Fraumeni
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

  5 in total
  6 in total

1.  Diffuse Signet-Ring Cell Gastric Adenocarcinoma "Linitis Plastica" and Pernicious Anemia: a Rare Association.

Authors:  Shounak Majumder; Hamid Habibi; Golam Gazi; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans.

Authors:  Annelie M Landgren; Ola Landgren; Gloria Gridley; Graça M Dores; Martha S Linet; Lindsay M Morton
Journal:  Cancer       Date:  2010-11-02       Impact factor: 6.860

3.  Diagnosis of pernicious anemia and the risk of pancreatic cancer.

Authors:  Pari Shah; Andrew D Rhim; Kevin Haynes; Wei-Ting Hwang; Yu-Xiao Yang
Journal:  Pancreas       Date:  2014-04       Impact factor: 3.327

4.  Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia.

Authors:  W Ye; O Nyrén
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

5.  Disease history and risk of comorbidity in women's life course: a comprehensive analysis of the Japan Nurses' Health Study baseline survey.

Authors:  Kazue Nagai; Kunihiko Hayashi; Toshiyuki Yasui; Kota Katanoda; Hiroyasu Iso; Yutaka Kiyohara; Akihiko Wakatsuki; Toshiro Kubota; Hideki Mizunuma
Journal:  BMJ Open       Date:  2015-03-11       Impact factor: 2.692

6.  Conditional Disease Development extracted from Longitudinal Health Care Cohort Data using Layered Network Construction.

Authors:  Venkateshan Kannan; Fredrik Swartz; Narsis A Kiani; Gilad Silberberg; Giorgos Tsipras; David Gomez-Cabrero; Kristina Alexanderson; Jesper Tegnèr
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.